No connection

Search Results

Corporate Score 35 Bearish

NuScale Power: Regulatory Lead Clashes with Commercial Cost Hurdles

Apr 27, 2026 20:20 UTC
SMR, OKLO
Long term

NuScale Power remains the only U.S. small modular reactor developer with NRC approval, yet high deployment costs continue to hinder commercial adoption. The company faces a critical juncture as it attempts to convert regulatory advantages into sustainable revenue.

  • Only SMR developer with current NRC design approval
  • Utilizes industry-standard light-water cooling technology
  • Romania project estimated at $7 billion for 460 MW
  • Previous Carbon Free Power Project canceled due to costs
  • Market cap currently sits at approximately $4 billion
  • Stock price has fallen nearly 70% over the last half-year

NuScale Power (NYSE: SMR) currently holds a unique position in the nuclear energy sector as the sole developer of small modular reactors (SMRs) with U.S. Nuclear Regulatory Commission (NRC) approval. This regulatory milestone, which includes the approval of its 77-megawatt design in May 2025, provides a significant first-mover advantage over competitors in the race to decarbonize the power grid. The company's success in navigating the NRC timeline is largely attributed to its reliance on light-water reactor technology. Because water-cooling is utilized in approximately 96% of existing nuclear plants, the design is familiar to regulators. This contrasts sharply with competitors like Oklo (NYSE: OKLO), which utilizes liquid sodium cooling—a technology that has not been commercially tested in the U.S. and has yet to receive full NRC approval. Despite the regulatory lead, financial viability remains a primary concern for investors. A planned project in Romania, intended to generate 460 megawatts via six modules, carries an estimated price tag of $7 billion. These high costs echo the failure of the Carbon Free Power Project (CFPP), NuScale's first planned project, which was canceled due to escalating expenses. Market sentiment has turned sharply negative, with the stock declining nearly 70% over the last six months. With a market capitalization of approximately $4 billion—roughly one-third that of Oklo—NuScale is increasingly viewed as a speculative play. The company must secure large-scale commercial contracts soon to prevent competitors from eroding its regulatory lead and capturing the emerging SMR market.

Sign up free to read the full analysis

Create a free account to unlock full AI-curated market articles, personalized alerts, and more.

Share this article

Related Articles

Stay Ahead of the Markets

Join thousands of traders using AI-powered market intelligence. Get personalized insights, real-time alerts, and advanced analysis tools.

Home
Terminal
AI Chat
Markets
Profile